title: Effect of structural modification on the gastrointestinal stability and hepatic metabolism of α-aminoxy peptides.
abstract: α-Aminoxy peptide AxyP1 has been reported to form synthetic chloride channel in living cells, thus it may have therapeutic potential for the treatment of diseases associated with chloride channel dysfunction. However, this study revealed significant gastrointestinal (GI) instability and extensive hepatic metabolism of AxyP1. To improve its GI and metabolic stability, structural modifications were conducted by replacing the isobutyl side chains of AxyP1 with methyl group (AxyP2), hydroxymethyl group (AxyP3), 4-aminobutyl group (AxyP4) and 3-carboxyl propyl group (AxyP5). Compared with AxyP1 (41 and 47 % degradation), GI stability of the modified peptides was significantly improved by 8-fold (AxyP2), 9-fold (AxyP3) and 12-fold (AxyP5) with no degradation for AxyP4 in simulated gastric fluid within 1 h, and by 12-fold (AxyP2) and 9-fold (AxyP3) with no degradation for AxyP4 and AxyP5 in simulated intestinal fluid within 3 h, respectively. The hepatic metabolic stability of the four modified peptides within 30 min in rat liver S9 preparation was also improved significantly with no metabolism of AxyP5 and threefold (AxyP2 and AxyP4) and eightfold (AxyP3) less metabolism compared with AxyP1 (39 % metabolism). Unlike hydrolysis as the major metabolism of peptides of natural α-amino acids, oxidation mediated by the cytochrome P450 enzymes, especially CYP3A subfamily, to form the corresponding mono-hydroxyl metabolites was the predominant hepatic metabolism of the five α-aminoxy peptides tested. The present findings demonstrate that structural modification can significantly improve the GI and metabolic stability of α-aminoxy peptides and thus increase their potential for therapeutic use in the treatment of chloride channel related diseases.
authors.affiliation: School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China.
authors.forename: Bin
authors.initials: B
authors.lastname: Ma
authors.forename: Chun
authors.initials: C
authors.lastname: Yin
authors.forename: Dan
authors.initials: D
authors.lastname: Yang
authors.forename: Ge
authors.initials: G
authors.lastname: Lin
mesh_terms: D000818:Animals; D040761:Biomimetic Materials / Q000737:chemistry; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D005750:Gastric Juice / Q000737:chemistry; D005765:Gastrointestinal Agents / Q000138:chemical synthesis* / Q000378:metabolism*; D007476:Ionophores / Q000138:chemical synthesis* / Q000378:metabolism*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D010455:Peptides / Q000138:chemical synthesis* / Q000378:metabolism*; D055550:Protein Stability; D051381:Rats; D017207:Rats, Sprague-Dawley; D013329:Structure-Activity Relationship; D053719:Tandem Mass Spectrometry
chemical_list: D005765:Gastrointestinal Agents; D007476:Ionophores; D010455:Peptides; D003577:Cytochrome P-450 Enzyme System